Study: NCT03996239

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: exercise (walking)
Description: Exercise treatment will consist of individualized walking delivered up to 5 times weekly. This trial will evaluate one dose of exercise (i.e., \~300 mins/wk following a non-linear dosing schedule) in both cohorts. Patients will have the option to receive exercise treatment at MSK or at their residence. Home-based exercise will be implemented and monitored using a telemedicine approach (i.e.,TeleEx) established in the Exercise-Oncology (ExOnc) Service

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: exercise (walking)
Description: Exercise treatment will consist of individualized walking delivered up to 5 times weekly. This trial will evaluate one dose of exercise (i.e., \~300 mins/wk following a non-linear dosing schedule) in both cohorts. Patients will have the option to receive exercise treatment at MSK or at their residence. Home-based exercise will be implemented and monitored using a telemedicine approach (i.e.,TeleEx) established in the Exercise-Oncology (ExOnc) Service

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: exercise (walking)
Description: Exercise treatment will consist of individualized walking delivered up to 5 times weekly. This trial will evaluate one dose of exercise (i.e., \~300 mins/wk following a non-linear dosing schedule) in both cohorts. Patients will have the option to receive exercise treatment at MSK or at their residence. Home-based exercise will be implemented and monitored using a telemedicine approach (i.e.,TeleEx) established in the Exercise-Oncology (ExOnc) Service

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: exercise (walking)
Description: Exercise treatment will consist of individualized walking delivered up to 5 times weekly. This trial will evaluate one dose of exercise (i.e., \~300 mins/wk following a non-linear dosing schedule) in both cohorts. Patients will have the option to receive exercise treatment at MSK or at their residence. Home-based exercise will be implemented and monitored using a telemedicine approach (i.e.,TeleEx) established in the Exercise-Oncology (ExOnc) Service

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: exercise (walking)
Description: Exercise treatment will consist of individualized walking delivered up to 5 times weekly. This trial will evaluate one dose of exercise (i.e., \~300 mins/wk following a non-linear dosing schedule) in both cohorts. Patients will have the option to receive exercise treatment at MSK or at their residence. Home-based exercise will be implemented and monitored using a telemedicine approach (i.e.,TeleEx) established in the Exercise-Oncology (ExOnc) Service

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: plasma samples
Description: Plasma samples will be obtained at baseline.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: plasma samples
Description: Plasma samples will be obtained at baseline.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: plasma samples
Description: Plasma samples will be obtained at baseline.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: blood draw
Description: fasting blood

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: blood draw
Description: fasting blood

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: blood draw
Description: fasting blood

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: blood draw
Description: fasting blood